Sabarubicin is a disaccharide analog of doxorubicin studied as an active pharmaceutical ingredient for small cell lung cancer research. It has shown superior antitumor efficacy in preclinical studies, associated with activation of p53-independent apoptosis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 211100-13-9
Idarubicin hydrochloride
pharmaceutical raw material
Idarubicin
pharmaceutical raw material
Diquafosol tetrasodium
pharmaceutical raw material
Gliclazide
pharmaceutical raw material
N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride
pharmaceutical raw material
Dabigatran
pharmaceutical raw material
(7S,9S)-7-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-8,10-dihydro-7H-tetracene-5,12-dione
VQHRZZISQVWPLK-UIRGBLDSSA-N
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@@H](O[C@H](C[C@@H]2O)O[C@H]3C[C@@](CC4=C3C(=C5C(=C4O)C(=O)C6=CC=CC=C6C5=O)O)(C(=O)CO)O)C)N)O